Molecular Modeling of the Antagonist Compound Esketamine and Its Molecular Docking Study With Non-Competitive N-Methyl-D-Aspartate (NMDA) Receptors NR1, NR2A, NR2B and NR2D
Progress in Chemical and Biochemical Research
doi 10.33945/sami/pcbr.2019.2.4
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2019
Authors
Unknown
Publisher
Sami Publishing Company